iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
In 2019, researchers reported a continuous-flow route that made a chiral intermediate used to produce the antidepressant (−)-paroxetine. The work was a laboratory process-development result—not evidence that paroxetine is made commercially by this method. The reported product was the intermediate, not the finished drug.
What the researchers made
Sándor B. Ötvös, Miquel A. Pericàs, and C. Oliver Kappe reported the work in Chemical Science in 2019. Their target was ((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methanol, a key chiral intermediate for (−)-paroxetine. The paper says the intermediate can be converted to the active pharmaceutical ingredient by etherification with sesamol, followed by removal of the nitrogen protecting group.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Organic Chemistry | $125.24 | Buy on Amazon |
| 2 |
|
Organic Chemistry (MasteringChemistry) | $319.99 | Buy on Amazon |
| 3 |
|
Organic Chemistry as a Second Language: First Semester Topics | $76.48 | Buy on Amazon |
| 4 |
|
Organic Chemistry | $65.32 | Buy on Amazon |
| 5 |
|
Organic Chemistry I For Dummies (For Dummies (Math & Science)) | $11.48 | Buy on Amazon |
The distinction matters: the reported flow process makes a precursor on the route to paroxetine; it does not, by itself, describe manufacture of the finished antidepressant.
Free tools Windows power users keep installed
One-click scans. No signup required.
How the continuous-flow route works
1. Set the stereochemistry with a supported organocatalyst
The route’s key asymmetric step is a solvent-free enantioselective conjugate addition. It uses a polystyrene-supported cis-4-hydroxydiphenylprolinol organocatalyst. Because the catalyst is supported on a solid, it is heterogeneous rather than dissolved in the reaction mixture.
#1 Best Overall
2. Telescope the downstream transformations
After the conjugate addition, the process runs a reductive amination, lactamization, and amide/ester reduction sequence as a telescoped operation. The authors describe heterogeneous catalytic hydrogenation and neat borane–dimethyl sulfide complex in the downstream sequence. “Telescoped” means consecutive transformations are carried out without isolating every intermediate between steps; it does not mean the route is a single chemical reaction.
What the reported performance figures mean
Ötvös, Pericàs, and Kappe report multigram-per-hour productivity and a cumulative E-factor of 6 for their process. These are claims about the authors’ reported experimental process in the 2019 paper, not independently verified plant performance or a commercial manufacturing benchmark.
Rank #2
An E-factor expresses process waste as a mass ratio: the mass of waste generated relative to the mass of product. A value of 6 is a process-specific metric, not proof that the route is environmentally benign in every manufacturing context. The paper’s solvent-free or highly concentrated conditions and use of robust heterogeneous catalysts are features of its process design, but they do not establish a full life-cycle or plant-scale environmental comparison.
What the study does—and does not—establish
The authors’ abstract describes the result as demonstrating catalytic enantioselective synthesis of the chiral key intermediate for (−)-paroxetine as a continuous-flow process on multigram scale. The paper was published in Chemical Science, volume 10, pages 11141–11146, after submission on 20 September 2019 and acceptance on 18 October 2019.
The study is evidence of a research-scale process-development achievement. The sources documenting this work do not establish later independent replication, current commercial availability, or industrial adoption. A reported multigram-scale flow route should not be read as proof that the method became the way paroxetine is manufactured.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Who reported the work
The authors were affiliated with the University of Graz and the Research Center Pharmaceutical Engineering in Austria, and the Institute of Chemical Research of Catalonia and University of Barcelona in Spain. Chemistry World’s 12 November 2019 report described it as a collaboration involving researchers in Austria and Spain.
Quick Recap
Best Value
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
